Pharmaceutical composition for treating duck virus hepatitis and preparation method thereof

Abstract

The invention discloses a pharmaceutical composition for treating duck virus hepatitis and a preparation method thereof. The pharmaceutical composition comprises the following raw material medicines: puffball, folium mori, honeysuckle, Rhizoma Cimicifugae, radix bupleuri, Amomum tsao-ko, sweet wormwood, antifebrile dichroa, black soybeans, root of rehmannia, root of common peony, Radix Ophiopogonis, lalang grass rhizome, Cacumen biotae, radix scrophulariae, lithospermum, fructus forsythiae, edible tulip, salvia chinensis, Uniflower Swisscentaury Root, leaf of purpleflower holly, Japanese Cayratia Herb, Saxifraga stolonifera, purslane, phoenix-tail fern and liquorice. The pharmaceutical composition has the beneficial effects that the pharmaceutical composition disclosed by the invention has the main effects of clearing away heat and toxic materials and activating blood circulation and cooling blood as well as auxiliary effects of tonifying qi and strengthening exterior, the body immunity of ill ducks can be improved, the pharmaceutical composition is good in curative effect and low in cost and price and does not have drug tolerance or drug residue, and the state of the illness can be effectively controlled.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese veterinary medicine, in particular to a pharmaceutical composition for treating duck viral hepatitis and a preparation method thereof. Background technique [0002] Duck viral hepatitis, referred to as duck hepatitis for short, is an acute severe infectious disease of ducklings caused by duck viral hepatitis virus, characterized by hemorrhagic inflammation in the liver. The disease was discovered for the first time in the United States in 1945 and named as type I duck viral hepatitis. In 1965, duck viral hepatitis type II was discovered in the United Kingdom. In 1969, duck viral hepatitis type III was discovered in the United States. At present, type I is distributed worldwide, and it has been reported that variant strains of type I duck hepatitis virus have been found in India, Egypt and the United States. Type II and Type III duck viral hepatitis were confined to the United Kingdom ...

AI Technical Summary

Problems solved by technology

However, Western medicine has a single regimen for duck viral hepatitis, limited drug varieties, long course of treatment, large drug residues, many adverse reactions, and unsatisfactory clinical efficacy.

Images